Repligen Corp/ US7599161095 /
20/12/2024 21:59:58 | Diferencia -2.13 | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
144.52USD | -1.45% | 50,595 Volumen de negocios: 7.48 millones |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 8.09 mil millonesUSD | - | 225.72 |
GlobeNewswire
06/05
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire
19/12/2023
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
07/12/2023
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convert...
GlobeNewswire
14/11/2023
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
GlobeNewswire
02/11/2023
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
GlobeNewswire
31/10/2023
Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
GlobeNewswire
02/10/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire
26/09/2023
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página